The stock of Repligen Corp (RGEN) has seen a 5.62% increase in the past week, with a -17.00% drop in the past month, and a -23.65% decrease in the past quarter. The volatility ratio for the week is 14.55%, and the volatility levels for the past 30 days are at 6.99% for RGEN. The simple moving average for the last 20 days is -9.78% for RGEN stock, with a simple moving average of -18.59% for the last 200 days.
Is It Worth Investing in Repligen Corp (NASDAQ: RGEN) Right Now?
Additionally, the 36-month beta value for RGEN is 1.23. There are mixed opinions on the stock, with 9 analysts rating it as a “buy,” 4 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”
The public float for RGEN is 53.02M and currently, short sellers hold a 6.68% ratio of that float. The average trading volume of RGEN on April 11, 2025 was 744.20K shares.
RGEN) stock’s latest price update
The stock price of Repligen Corp (NASDAQ: RGEN) has surged by 2.64 when compared to previous closing price of 115.19, but the company has seen a 5.62% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-04-08 that WALTHAM, Mass., April 08, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN) today announced the appointment of Jacob Johnson as Vice President, Investor Relations. In this role, Mr. Johnson will lead the investor relations team’s engagement with the investment community, reporting to the company’s Chief Financial Officer, Jason K. Garland. Most recently, Mr. Johnson served as Managing Director, Research Analyst at Stephens Inc., where he followed the life sciences tools and pharma services sector.
Analysts’ Opinion of RGEN
Many brokerage firms have already submitted their reports for RGEN stocks, with Evercore ISI repeating the rating for RGEN by listing it as a “In-line.” The predicted price for RGEN in the upcoming period, according to Evercore ISI is $155 based on the research report published on March 18, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see RGEN reach a price target of $200. The rating they have provided for RGEN stocks is “Buy” according to the report published on February 10th, 2025.
Canaccord Genuity gave a rating of “Hold” to RGEN, setting the target price at $165 in the report published on December 17th of the previous year.
RGEN Trading at -18.55% from the 50-Day Moving Average
After a stumble in the market that brought RGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.22% of loss for the given period.
Volatility was left at 6.99%, however, over the last 30 days, the volatility rate increased by 14.55%, as shares sank -21.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.40% lower at present.
During the last 5 trading sessions, RGEN rose by +5.66%, which changed the moving average for the period of 200-days by -3.95% in comparison to the 20-day moving average, which settled at $131.05. In addition, Repligen Corp saw -17.86% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RGEN starting from Hunt Anthony, who sale 26,756 shares at the price of $152.51 back on Mar 17 ’25. After this action, Hunt Anthony now owns 136,301 shares of Repligen Corp, valued at $4,080,663 using the latest closing price.
Pax Margaret, the Director of Repligen Corp, purchase 250 shares at $150.69 during a trade that took place back on Mar 17 ’25, which means that Pax Margaret is holding 1,043 shares at $37,672 based on the most recent closing price.
Stock Fundamentals for RGEN
Current profitability levels for the company are sitting at:
- -0.07 for the present operating margin
- 0.49 for the gross margin
The net margin for Repligen Corp stands at -0.05. The total capital return value is set at -0.02. Equity return is now at value -1.30, with -0.90 for asset returns.
Based on Repligen Corp (RGEN), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at 0.26. The debt to equity ratio resting at 0.34. The interest coverage ratio of the stock is -2.57.
Currently, EBITDA for the company is 113.34 million with net debt to EBITDA at -0.7. When we switch over and look at the enterprise to sales, we see a ratio of 10.4. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.41.
Conclusion
In conclusion, Repligen Corp (RGEN) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
